X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-16 | TRDA | Sethuraman Natarajan | Pres, Research, Develop. | S - Sale | $18.00 | -600 | 183,216 | 0% | -$10,800 | ||||||
2024-09-26 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $16.00 | -847 | 125,149 | -1% | -$13,552 | ||||||
2024-09-09 | TRDA | Wentworth Kory James | CFO | S - Sale | $14.97 | -3,195 | 76,486 | -4% | -$47,832 | ||||||
| M | 2024-09-06 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $15.09 | -2,303 | 125,996 | -2% | -$34,753 | |||||
| M | 2024-09-06 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $15.12 | -3,242 | 183,816 | -2% | -$49,004 | |||||
| D | 2024-08-16 | TRDA | Dowden Nathan J | Pres, COO | S - Sale+OE | $16.27 | -27,097 | 130,107 | -17% | -$440,801 | |||||
| M | 2024-07-12 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $18.00 | -1,238 | 188,814 | -1% | -$22,284 | |||||
| M | 2024-07-12 | TRDA | Doshi Dipal | CEO | S - Sale | $17.84 | -1,900 | 334,475 | -1% | -$33,897 | |||||
2024-07-08 | TRDA | Wentworth Kory James | CFO | S - Sale | $14.95 | -1,758 | 81,412 | -2% | -$26,282 | ||||||
2024-06-13 | TRDA | Doshi Dipal | CEO | S - Sale | $16.17 | -1,000 | 336,375 | 0% | -$16,174 | ||||||
| M | 2024-05-16 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $15.16 | -18,980 | 190,052 | -9% | -$287,695 | |||||
| M | 2024-05-16 | TRDA | Doshi Dipal | CEO | S - Sale | $15.04 | -3,000 | 337,375 | -1% | -$45,129 | |||||
2024-05-14 | TRDA | Kim Peter S | Dir | P - Purchase | $14.59 | +25,000 | 92,412 | +37% | +$364,673 | ||||||
| M | 2024-05-08 | TRDA | Kim Peter S | Dir | P - Purchase | $14.14 | +4,476 | 67,412 | +7% | +$63,306 | |||||
2024-04-08 | TRDA | Kim Peter S | Dir | P - Purchase | $13.57 | +2,600 | 62,936 | +4% | +$35,290 | ||||||
2024-03-28 | TRDA | Kim Peter S | Dir | P - Purchase | $13.75 | +1,512 | 60,336 | +3% | +$20,794 | ||||||
| M | 2024-03-22 | TRDA | Kim Peter S | Dir | P - Purchase | $13.58 | +9,048 | 58,824 | +18% | +$122,882 | |||||
| M | 2024-03-19 | TRDA | Kim Peter S | Dir | P - Purchase | $12.81 | +2,732 | 49,776 | +6% | +$34,996 | |||||
2024-03-06 | TRDA | Wentworth Kory James | CFO | S - Sale | $12.31 | -4,086 | 74,170 | -5% | -$50,285 | ||||||
2024-03-06 | TRDA | Dowden Nathan J | Pres, COO | S - Sale | $12.32 | -1,826 | 137,204 | -1% | -$22,499 | ||||||
2024-02-15 | TRDA | Doshi Dipal | CEO | S - Sale | $15.00 | -1,000 | 243,279 | 0% | -$15,000 | ||||||
2024-01-16 | TRDA | Doshi Dipal | CEO | S - Sale | $15.99 | -1,000 | 244,279 | 0% | -$15,990 | ||||||
| DM | 2023-12-21 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $15.59 | -12,500 | 49,571 | -20% | -$194,845 | |||||
2023-12-20 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 245,279 | 0% | -$15,000 | ||||||
2023-11-13 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $16.23 | -1,000 | 246,279 | 0% | -$16,230 | ||||||
2023-10-17 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 247,279 | 0% | -$15,000 | ||||||
2023-09-13 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.00 | -1,000 | 248,279 | 0% | -$15,000 | ||||||
| D | 2023-09-06 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $13.48 | -950 | 49,571 | -2% | -$12,806 | |||||
| D | 2023-09-06 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $13.48 | -892 | 40,037 | -2% | -$12,022 | |||||
| D | 2023-09-06 | TRDA | Dowden Nathan J | COO | S - Sale+OE | $13.47 | -972 | 48,168 | -2% | -$13,089 | |||||
2023-08-14 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.67 | -1,000 | 201,069 | 0% | -$15,671 | ||||||
| DM | 2023-08-02 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $14.76 | -26,710 | 27,130 | -50% | -$394,219 | |||||
| DM | 2023-07-10 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $17.99 | -10,000 | 36,747 | -21% | -$179,862 | |||||
| M | 2023-07-10 | TRDA | Dowden Nathan J | COO | S - Sale | $18.03 | -7,097 | 35,376 | -17% | -$127,938 | |||||
| M | 2023-07-10 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $18.03 | -17,878 | 153,447 | -10% | -$322,389 | |||||
| D | 2023-06-21 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $15.01 | -17,500 | 27,957 | -38% | -$262,648 | |||||
| M | 2023-06-20 | TRDA | Dowden Nathan J | COO | S - Sale | $15.42 | -15,982 | 42,473 | -27% | -$246,403 | |||||
2023-04-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $13.71 | -2,000 | 202,069 | -1% | -$27,422 | ||||||
2023-04-17 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $18.01 | -2,092 | 204,069 | -1% | -$37,675 | ||||||
2023-04-17 | TRDA | Sethuraman Natarajan | Chief Scientific Officer | S - Sale | $18.00 | -3,961 | 171,325 | -2% | -$71,316 | ||||||
2023-03-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $14.72 | -2,000 | 255,811 | -1% | -$29,435 | ||||||
| D | 2023-03-02 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $10.53 | -1,747 | 42,157 | -4% | -$18,389 | |||||
| D | 2023-03-02 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $10.56 | -1,641 | 41,330 | -4% | -$17,336 | |||||
2023-02-28 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -2,000 | 161,835 | -1% | -$24,000 | ||||||
2023-01-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $12.00 | -2,000 | 163,835 | -1% | -$24,001 | ||||||
2023-01-09 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.02 | -2,410 | 165,835 | -1% | -$36,196 | ||||||
2022-12-30 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale | $13.45 | -5,200 | 15,516 | -25% | -$69,932 | ||||||
| M | 2022-12-27 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $15.02 | -14,590 | 168,245 | -8% | -$219,119 | |||||
| D | 2022-12-08 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.95 | -4,550 | 16,509 | -22% | -$86,238 | |||||
| DM | 2022-12-02 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.19 | -3,110 | 16,509 | -16% | -$56,559 | |||||
2022-11-28 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $13.91 | -2,000 | 182,835 | -1% | -$27,826 | ||||||
| D | 2022-11-16 | TRDA | Wentworth Kory James | CFO | S - Sale+OE | $18.10 | -200 | 16,509 | -1% | -$3,620 | |||||
2022-10-31 | TRDA | Dowden Nathan J | COO | S - Sale | $24.05 | -2,100 | 45,283 | -4% | -$50,495 | ||||||
| DM | 2022-10-25 | TRDA | Kreher Nerissa | Chief Medical Officer | S - Sale+OE | $21.27 | -13,000 | 20,716 | -39% | -$276,549 | |||||
2022-10-25 | TRDA | Dowden Nathan J | COO | S - Sale | $20.77 | -9,348 | 47,383 | -16% | -$194,191 | ||||||
| M | 2022-10-25 | TRDA | Doshi Dipal | Pres, CEO | S - Sale | $20.80 | -14,061 | 184,835 | -7% | -$292,512 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |